bullish
ERIS Lifesciences Limited – Acquisition Led Growth Story
217 Views14 Mar 2018 20:48
Eris Lifesciences Limited (ERIS IN) is engaged in the marketing and manufacturing of branded generic drugs and derives all its revenues from the...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 24-minute read)
Discussions
(Paid Plans Only)
Trivikram Consultants
Picking Long Term Multi-bagger stocks
Price Chart(Sign Up to Access)
- ERIS Lifesciences – FY18 Annual Report Analysis - Strong Rebound in Cash Flow Likely from FY19E12 Oct 2018
- Eris Lifesciences - 1QFY19 – Strides Assimilation on Track21 Aug 2018
- Eris Lifesciences Ltd - Q4FY18 Beats Expectations, FY19E on Track31 May 2018
- ERIS Lifesciences Limited – Acquisition Led Growth Story14 Mar 2018
x